Stock To Watch: IDEXX Laboratories, Inc. (NASDAQ:IDXX)


The leading market experts have placed a mean price target of $82.800 on IDEXX Laboratories, Inc. (NASDAQ:IDXX) stock. This price level, which is estimated to be attained in one-year indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $0.590 a share for the upcoming quarter and $2.210 for the current fiscal. Technical View The technical analysis of IDEXX Laboratories, Inc. plainly substantiates that the 50-day moving average of IDEXX Laboratories, Inc. is $88.760, and stock is hovering 2.295 or +2.585% distant from $88.760. It is noted that the 200-day MA is $78.303, and IDEXX Laboratories, Inc. stock is $12.752 or +16.285% off from this point. IDEXX Laboratories, Inc. (NASDAQ:IDXX) 52-week high is $91.940 and the 52-week low is $61.580. This explains if the stock moves $-0.885, it will post a 52-week high. In event of $+47.865% points decline, a 52-week low will be hit. Taking the Valuation Aspect To emphasize the valuation of IDEXX Laboratories, Inc., shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, IDEXX Laboratories, Inc. (NASDAQ:IDXX) ratio came in at 43.967. The stock last ended the trading session at $91.055 and registered a market cap of $8.15B. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. IDEXX Laboratories, Inc. (NASDAQ:IDXX) PEG ratio is at 3.040.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 3 times, 1 visits today)